|Category:||Emerging Biotech Company Presentation|
|Time:||13:15 – 13:30|
Scailyte is a globally recognized spin-off from ETH Zürich and pioneer in the field of single-cell data analysis (Nature Spinoff Award, Forbes Top30 in AI, Masschallenge winner, Swiss Top100 Startups). Scailyte’s mission is to discover and develop biomarkers for precision medicine using single-cell and multi-omics data. We have successfully developed biomarkers in oncology and women’s health and we are looking to partner with biotech and diagnostic companies in these areas.